Stockreport

Benitec Provides Update on BB-401 Cancer Treatment Program

Benitec Biopharma Inc.  (BNTC) 
US:NASDAQ Investor Relations: benitec.com/for-investors/investor-faqs
PDF SYDNEY and HAYWARD, Calif., Dec. 21, 2018 /PRNewswire/ -- Benitec Biopharma (ASX: BLT, NADSAQ: BNTC) (the "Company"), a clinical-stage biotechnology company developin [Read more]